Kamal Adawi Insider Profile
4 Followers
Kamal Adawi, CFO at Fate Therapeutics, holds 100.00K shares in Fate Therapeutics (Ticker: FATE), holds 243.75K shares in Exagen (Ticker: XGN).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-45.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kamal Adawi holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kamal Adawi
Kamal Adawi's Trading History
Fate Therapeutics
Jan 16, 2026
CFO
Uninformative Buy
―
$231.00K
Exagen
Mar 06, 2024
CFO and Corporate Secretary
Informative Sell
24.29K
$1.71M
List of latest transactions for each holding click on a transaction to see Kamal Adawi's performance on stock
You May Also Like
Kamal Adawi insider profile FAQ
What is the percentage of profitable transactions made by Kamal Adawi?
The percentage of profitable transactions made by Kamal Adawi is 50%.
What is the average return per transaction made by Kamal Adawi?
The average return per transaction made by Kamal Adawi is -45.70%.
What stocks does Kamal Adawi hold?
Kamal Adawi holds: FATE, XGN stocks.
What was Kamal Adawi’s latest transaction?
Kamal Adawi latest transaction was an Uninformative Buy of ―.
What was Kamal Adawi's most profitable transaction?
Kamal Adawi’s most profitable transaction was an Informative Sell of XGN stock on February 10, 2023. The return on the trade was 18.30%.
What is Kamal Adawi's role in Fate Therapeutics?
Kamal Adawi's role in Fate Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.